Auristatin Impurity 4 | CAS 157967-06-1 - Request Quote
Auristatin Impurity 4
| SZ CAT No: | SZ-A197008 |
| CAS No | 157967-06-1 |
| Mol.F. | C14H25NO5 |
| Mol.Wt. | 287.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Auristatin Impurity 4 is chemically (2R,3S)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoic acid. Auristatin Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Auristatin Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Auristatin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 157967-06-1
Purchase 157967-06-1
Order 157967-06-1
Enquire 157967-06-1
price of 157967-06-1
157967-06-1 Supplier
157967-06-1 Manufacturer
157967-06-1 Exporter
buy high quality Auristatin Impurity 4
Purchase Auristatin Impurity 4
Auristatin Impurity 4 suppliers
Auristatin Impurity 4 manufacturers
Auristatin Impurity 4 price
Order Auristatin Impurity 4
Enquire Auristatin Impurity 4
Auristatin Impurity 4 cost
Auristatin Impurity 4 Supplier
Auristatin Impurity 4 Distributor
Auristatin Impurity 4 for Method Validation
Auristatin Reference Standard
Auristatin Impurity 4 for ANDA Filing
Auristatin Impurity 4 for Forced Degradation Studies
Auristatin Impurity 4 Identification Standards
Auristatin Impurity 4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.